主动脉瓣瓣中瓣术后残余狭窄的发生率、预测因素与临床结局
本研究纳入910例主动脉瓣瓣中瓣(ViV)患者,分析残余压差升高(≥20 mmHg)和患者-人工瓣膜不匹配(PPM)的发生率、预测因素及与临床结局的关联。结果显示中度以上PPM占61%、重度PPM占24.6%、残余压差升高占27.9%,但重度PPM或压差升高与VARC II定义的结局或1年生存率均无关联(90.9% vs 91.5% vs 89.3%,P=0.44)。
要点
- 主动脉ViV术后中度以上PPM达61%,重度PPM达24.6%,残余压差升高达27.9%。
- 基础压差高、带支架生物瓣、高BMI及SAPIEN系列瓣膜与重度PPM独立相关。
- 重度PPM或残余压差升高未与VARC II结局或1年生存率相关。
核心结论
- 主动脉ViV术后重度PPM和残余压差升高非常常见,但与短期生存及临床结局无关联。
- ViV术后不良血流动力学对临床结局的长期影响仍需进一步评估。
研究设计与样本
- 研究纳入910例主动脉瓣瓣中瓣(ViV)患者。
- 残余压差升高定义为≥20 mmHg。
- PPM基于超声心动图测得的指数化有效瓣口面积(EOA)和患者体重指数(BMI)判定,按欧洲心血管影像协会(EACVI)标准分为中度与重度,并与无PPM患者比较。
主要发现
- 中度或以上PPM见于61%的患者,重度PPM见于24.6%。
- 残余压差升高见于27.9%的患者。
- 发生较低指数化EOA(即重度PPM)的独立危险因素包括:基线失败生物瓣压差较高(非标准化beta -0.023;95%CI -0.032至-0.014;P<0.001)、带支架(vs无支架)外科生物瓣(非标准化beta -0.11;95%CI -0.161至-0.071;P<0.001)、较高BMI(非标准化beta -0.01;95%CI -0.013至-0.007;P<0.001)及植入SAPIEN/SAPIEN XT/SAPIEN 3经导管瓣膜(非标准化beta -0.064;95%CI -0.095至-0.032;P<0.001)。
- 重度PPM或残余压差升高均与VARC II定义的结局或1年生存率无关联(90.9%重度 vs 91.5%中度 vs 89.3%无,P=0.44)。
关键数值与推荐
- 残余压差升高定义为≥20 mmHg。
- PPM基于超声心动图测得的指数化有效瓣口面积(EOA)和患者体重指数(BMI),按EACVI标准分为中度与重度。
临床怎么用
- 主动脉ViV术后应关注PPM和残余压差升高,但短期预后似乎不受其显著影响。
- 对基线压差高、使用带支架生物瓣、高BMI或植入SAPIEN系列瓣膜的患者,需警惕重度PPM风险。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to analyse the incidence of prosthesis-patient mismatch (PPM) and elevated gradients after aortic valve in valve (ViV), and to evaluate predictors and associations with clinical outcomes of this adverse event. METHODS: A total of 910 aortic ViV patients were investigated. Elevated residual gradients were defined as ≥20 mm Hg. PPM was identified based on the indexed effective orifice area (EOA), measured by echocardiography, and patient body mass index (BMI). Moderate and severe PPM (cases) were defined by European Association of Cardiovascular Imaging (EACVI) criteria and compared with patients without PPM (controls). RESULTS: Moderate or greater PPM was found in 61% of the patients, and severe in 24.6%. Elevated residual gradients were found in 27.9%. Independent risk factors for the occurrence of lower indexed EOA and therefore severe PPM were higher gradients of the failed bioprosthesis at baseline (unstandardised beta -0.023; 95% CI -0.032 to -0.014; P<0.001), a stented (vs a stentless) surgical bioprosthesis (unstandardised beta -0.11; 95% CI -0.161 to -0.071; P<0.001), higher BMI (unstandardised beta -0.01; 95% CI -0.013 to -0.007; P<0.001) and implantation of a SAPIEN/SAPIEN XT/SAPIEN 3 transcatheter device (unstandardised beta -0.064; 95% CI -0.095 to -0.032; P<0.001). Neither severe PPM nor elevated gradients had an association with VARC II-defined outcomes or 1-year survival (90.9% severe vs 91.5% moderate vs 89.3% none, P=0.44). CONCLUSIONS: Severe PPM and elevated gradients after aortic ViV are very common but were not associated with short-term survival and clinical outcomes. The long-term effect of poor post-ViV haemodynamics on clinical outcomes requires further evaluation.
引用
- Bleiziffer S, Erlebach M, Simonato M, et al. Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve. Heart. 2018. PMID: 29352008. doi:10.1136/heartjnl-2017-312422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。